CCGs already improving patient care
July 23, 2012Sales and Marketing CCGs, Commissioning Board, GPs, NHS, NHSCC, reforms
Clinical Commissioning Groups – the new structures set up under the Health and Social Care Act to control most of …
Onyx appoints John Osborn as senior VP
July 20, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing John Osborn, Onyx
Onyx Pharmaceuticals has announced the appointment of John Osborn as senior vice president, Global Corporate Affairs. In his role, Osborn …
Waggener Edstrom appoints vice president
July 20, 2012Business Services, Medical Communications, Sales and Marketing Anna Gray, Waggener Edstrom
Comms agency Waggener Edstrom has announced that Anna Gray has been appointed to lead the agency’s UK Healthcare Practice. Joining …
Grünenthal and Vifor breach Code
July 20, 2012Sales and Marketing ABPI, Grunenthal, PMCPA, Vifor, code, tapentadol
Grünenthal and Vifor Pharma UK have been named and shamed for serious infringements of the ABPI Code of Practice. Adverts …
Humira powers ahead as Abbott prepares split
July 19, 2012Sales and Marketing AbbVie, Abbott, Humira, RA
Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …
Home Digital appoints Doctors.net.uk senior head
July 19, 2012Business Services, Medical Communications, Sales and Marketing Doctors.net.uk, Home Digital
Digital marketing agency Home Digital has hired Marie Little as the company’s commercial director. In this newly created role she …
Senior appointments for Takeda’s Europe and Canada team
July 18, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda
Takeda Pharmaceuticals has appointed David Milton as head of Marketing & Product Portfolio Strategy, and Dr Nizamul Islam as head …
New J&J chief still struggling with scandals
July 18, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Risperdal, Weldon, Xarelto, Zytiga
Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …
GSK raises stake in Amicus for Fabry drug
July 18, 2012Research and Development, Sales and Marketing Amicus, Fabry, GSK, R&D
GlaxoSmithKline is to increase ownership in Amicus Therapeutics as the firms extend their collaboration to find a new drug for …
Curemark announces executive promotions
July 18, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Curemark
Curemark has announced the appointment of Matthew Heil to the position of chief scientific officer. Currently, Dr Heil is serving …
Conatus appoints Corporate Development head
July 18, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Conatus, emricasan
Conatus Pharmaceuticals has announced the appointment of Daniel Ripley as head of Corporate Development. Ripley will lead the commercialisation strategy …
‘Golden parachute’ for AZ’s David Brennan
July 17, 2012Sales and Marketing AstraZeneca, David Brennan, GMB
David Brennan, the former chief executive of AstraZeneca, could receive more than £4million as a payout after being ousted from …
EMA appoints head of International and European Co-operation
July 17, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA
The European Medicines Agency has appointed Emer Cooke as Head of International and European Co-operation. The International and European Co-operation …
Glaxo seals $3 billion acquisition of HGS
July 17, 2012Business Services, Research and Development, Sales and Marketing Benlysta, GSK, Human Genome Sciences, R&D
GlaxoSmithKline has finally sealed the acquisition of Human Genome Sciences, the company with which it co-markets lupus treatment Benlysta. The …
Spink expands ethical health team
July 17, 2012Business Services, Medical Communications, Sales and Marketing Spink
Communications firm Spink has strengthened its ethical division with three appointments to work on its healthcare portfolio. Account director Martha …
Spanish API supplier Ercros warned by FDA
July 17, 2012Manufacturing and Production Ercros, FDA, GMP
Spanish chemical supplier Ercros SA has been sent a warning letter from the FDA after an inspection picked up a …
BMS unveils $165m expansion in Puerto Rico
July 17, 2012Manufacturing and Production BMS, Puerto Rico, diabetes, manufacturing
A facility operated by Bristol-Myers Squibb in Puerto Rico stands to benefit from a $165 million investment programme that will …
Fishawack Group boosts client service team
July 16, 2012Business Services, Medical Communications, Research and Development, Sales and Marketing Fishawhack, Med Comms
The Fishawack Group of companies has appointed Glenn Wilson (pictured), Sissy Easo-Joseph and Anna Timbrell to client service positions across …
Huge increase in emerging market spending to lift pharma
July 16, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging
The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …
GSK and Theravance file COPD drug
July 16, 2012Research and Development, Sales and Marketing EMA, GSK, Relovair, Revlar, Spiriva, Theravance
GlaxoSmithKline and US biopharma firm Theravance have submitted their investigational chronic obstructive pulmonary disease (COPD) drug to regulators in Europe …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
